Literature DB >> 11304850

Thyroglobulin immunoreactivity in lymph node histiocytes: a potential diagnostic pitfall.

L Venkatraman1, P Maxwell, W G McCluggage.   

Abstract

AIMS: Strong thyroglobulin immunoreactivity within sinus histiocytes in a lymph node draining a papillary thyroid carcinoma was observed in a recent case. This prompted the investigation of whether thyroglobulin immunoreactivity is common in regional lymph nodes in cases of thyroid malignancy.
METHODS: Eighty seven lymph nodes were studied from 21 cases of thyroid malignancy. These comprised papillary carcinoma (n = 12), follicular carcinoma (n = 4), medullary carcinoma (n = 3), and one case each of squamous and anaplastic carcinoma. Eleven cervical lymph nodes from patients with no evidence of thyroid disease were included as controls. Sections were stained with a monoclonal antibody against thyroglobulin.
RESULTS: In the cases of thyroid malignancy, 32 of 87 lymph nodes showed positive staining for thyroglobulin of histiocytes within the subcapsular and medullary sinuses. In an additional four cases, there was positive staining of lymph within lymphatic channels. Positivity was present in at least one node in 15 of 21 cases. There was no positivity in the control cases. There was no correlation between the size of the primary tumour and the presence of thyroglobulin positivity.
CONCLUSIONS: Positive staining with antithyroglobulin occurs not uncommonly in sinus histiocytes in lymph nodes draining thyroid tumours. This positivity could be the result of the destruction of normal thyroid follicles, with the release of thyroglobulin, which is taken up by histiocytes, which subsequently drain to local lymph nodes. Pathologists should be aware of this phenomenon and should be careful not to interpret this as metastatic tumour.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304850      PMCID: PMC1731390          DOI: 10.1136/jcp.54.4.314

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Epithelial markers in thyroid carcinoma: an immunoperoxidase study.

Authors:  N W Wilson; H Pambakian; T C Richardson; M R Stokoe; C A Makin; E Heyderman
Journal:  Histopathology       Date:  1986-08       Impact factor: 5.087

2.  Clear cell change in primary thyroid tumors. A study of 38 cases.

Authors:  M L Carcangiu; R K Sibley; J Rosai
Journal:  Am J Surg Pathol       Date:  1985-10       Impact factor: 6.394

3.  Diagnosis of primary thyroid carcinoma by immunohistological demonstration of thyroglobulin.

Authors:  A Burt; R B Goudie
Journal:  Histopathology       Date:  1979-07       Impact factor: 5.087

4.  Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy.

Authors:  M L Carcangiu; G Zampi; A Pupi; A Castagnoli; J Rosai
Journal:  Cancer       Date:  1985-02-15       Impact factor: 6.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.